Heterozygous Familial Hypercholesterolemia (HeFH) trials recruiting in Massachusetts

Fewer than 3 recruiting trials found.

All Heterozygous Familial Hypercholesterolemia (HeFH) trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
  NCT07058077 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Massachusetts: Boston